手持式超音波心动图设备市场- 按产品（诊断[静止、压力]、监测[可穿戴、MCT]）、导极类型（单导联、3 导联、6 导程、12 导程）、最终用途（医院、诊所、诊断中心、 ASC) - 全球预测，2024 - 2032

受心血管疾病(CVD) 盛行率上升、手持式超音波心动图设备技术进步以及人们对早期检测和监测心臟病意识不断增强的推动，全球手持式超音波心动图设备市场在2024 年至2032 年期间将以4.5% 的复合年增长率成长。

据世界卫生组织称，心血管疾病每年夺走约 1,790 万人的生命，成为全球死亡的主要原因。由于心血管疾病在全球死亡率中占相当大的比例，因此迫切需要有效的诊断工具来实现早期发现和介入。手持式超音波心动图设备为医疗保健专业人员提供了一种便携式且易于使用的解决方案，可以及时进行心臟评估，从而促进心血管疾病的主动管理。在久坐的生活方式、不健康的饮食习惯和人口老化等因素的推动下，全球心血管疾病的负担持续升级，手持式超音波心动图设备的需求预计将猛增，推动未来几年的市场成长。

手持式超音波心动图设备产业根据产品、引线类型、最终用途和地区进行分类。

到 2032 年，监测领域将出现显着增长，因为超音波心动图设备可以在从重症监护室到门诊诊所的各种临床环境中连续监测心臟功能。感测器技术和资料分析的进步使得手持设备的开发能够提供全面的血流动力学评估，包括心输出量、射血分数和瓣膜功能的测量，从而促进细分市场的成长。

由于手持式超音波心动图设备卓越的成像能力和诊断准确性，到 2032 年，三导联手持式超音波心动图设备市场份额将大幅增长。这些设备利用先进的换能器技术和复杂的演算法来即时产生心臟的三维影像，为临床医生提供心臟解剖和功能无与伦比的见解。从多个角度可视化心臟结构的能力增强了诊断信心，同时促进更精确的治疗计划，特别是在先天性心臟缺陷和结构性心臟病等复杂病例中。

在快速城市化、扩大医疗基础设施和增加医疗支出的推动下，亚太地区手持式超音波心动图设备产业将在 2024 年至 2032 年间以良好的速度成长。中国、印度和日本等国家的心血管疾病负担日益加重，对先进诊断解决方案产生了巨大需求。此外，旨在改善医疗服务取得和促进预防心臟病学的政府措施进一步推动了该地区的市场成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 远距患者监护的需求不断增加
    • 技术进步
    • 心血管疾病发生率上升
    • 人口老化加剧和家庭医疗保健趋势
  • 产业陷阱与挑战
    • 法规遵从性和标准化
    • 与传统心电图系统相比，诊断能力有限
• 成长潜力分析
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年

• 主要趋势
• 诊断心电图机
  • 静止心电图
  • 压力心电图
• 监护心电图设备
  • 动态心电图监测仪
  • 移动心臟遥测 (MCT)
  • 穿戴式心电图设备
  • 其他设备

第 6 章：市场估计与预测：按铅类型，2018 - 2032 年

• 主要趋势
• 单引线型
• 3引线型
• 6引线型
• 12引线型
• 其他引线类型

第 7 章：市场估计与预测：按最终用途，2018 - 2032 年

• 主要趋势
• 医院和诊所
• 诊断中心
• 门诊手术中心
• 家庭护理设置
• 其他最终用户

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• AliveCor, Inc.
• Allengers Medical Systems, Ltd.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Fukuda Denshi Co., Ltd.
• GE HealthCare Technologies Inc.
• Hill-Rom Holdings, Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Global Handheld Echocardiography Devices Market will grow at 4.5% CAGR during 2024-2032, driven by the rising prevalence of cardiovascular diseases (CVDs), technological advancements in handheld echocardiography devices, and growing awareness of early detection and monitoring of cardiac conditions.

According to WHO, cardiovascular diseases claim approximately 17.9 million lives annually, becoming the primary cause of death worldwide. With CVDs accounting for a considerable portion of global mortality rates, there is an urgent need for efficient diagnostic tools to enable early detection and intervention. Handheld echocardiography devices offer a portable and accessible solution for healthcare professionals to conduct timely cardiac assessments, thereby facilitating proactive management of CVDs. As the burden of cardiovascular diseases continues to escalate worldwide, fueled by factors such as sedentary lifestyles, unhealthy dietary habits, and aging populations, the demand for handheld echocardiography devices is expected to soar, driving market growth in the coming years.

The Handheld Echocardiography Devices Industry is classified based on product, lead type, end-use, and region.

The monitoring segment will register significant growth by 2032, as echocardiography devices allow for continuous monitoring of cardiac function in various clinical settings, ranging from intensive care units to outpatient clinics. Advancements in sensor technology and data analytics have enabled the development of handheld devices capable of providing comprehensive hemodynamic assessments, including measurement of cardiac output, ejection fraction, and valve function, thereby enhancing segment growth.

The handheld echocardiography devices market share from the 3 leads segment will grow substantially through 2032 due to the superior imaging capabilities and diagnostic accuracy of handheld echocardiography devices. These devices utilize advanced transducer technology and sophisticated algorithms to generate three-dimensional images of the heart in real time, offering clinicians unparalleled insights into cardiac anatomy and function. The ability to visualize cardiac structures from multiple angles enhances diagnostic confidence while facilitating more precise treatment planning, particularly in complex cases such as congenital heart defects and structural heart diseases.

Asia Pacific Handheld Echocardiography Devices Industry will grow at a decent pace between 2024 and 2032, driven by rapid urbanization, expanding healthcare infrastructure, and increasing healthcare expenditure. Countries such as China, India, and Japan are witnessing a growing burden of cardiovascular diseases, creating a significant demand for advanced diagnostic solutions. Moreover, government initiatives aimed at improving access to healthcare services and promoting preventive cardiology are further fueling market growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for remote patient monitoring
    • 3.2.1.2 Advancements in technology
    • 3.2.1.3 Rising cardiovascular disease incidence
    • 3.2.1.4 Increasing aging population and home healthcare trends
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Regulatory compliance and standardization
    • 3.2.2.2 Limited diagnostic capability compared to traditional ECG systems
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Diagnostics ECG machines
  • 5.2.1 Resting ECG
  • 5.2.2 Stress ECG
• 5.3 Monitoring ECG devices
  • 5.3.1 Holter monitors
  • 5.3.2 Mobile cardiac telemetry (MCT)
  • 5.3.3 Wearable ECG devices
  • 5.3.4 Other devices

Chapter 6 Market Estimates and Forecast, By Lead Type, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Single lead type
• 6.3. 3 lead type
• 6.4. 6 lead type
• 6.5. 12 lead type
• 6.6 Other lead types

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals & clinics
• 7.3 Diagnostic centers
• 7.4 Ambulatory surgical centers
• 7.5 Home care settings
• 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 AliveCor, Inc.
• 9.2 Allengers Medical Systems, Ltd.
• 9.3 Biotronik SE & Co. KG
• 9.4 Boston Scientific Corporation
• 9.5 Fukuda Denshi Co., Ltd.
• 9.6 GE HealthCare Technologies Inc.
• 9.7 Hill-Rom Holdings, Inc.
• 9.8 Koninklijke Philips N.V.
• 9.9 Medtronic plc
• 9.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.